Augmented Virtual Reality for Reducing Pain, Stress, Anxiety and Improve Self Efficacy in Adult Cancer Patients Undergoing Chemotherapy in The West Bank
CompletedNot applicableNCT07152938
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The main purpose of this study is to examine the effect of using AVR on pain, stress, anxiety, and SE among adult cancer patients undergoing chemotherapy in the West Bank hospitals in Palestine. The main questions it aims to answer are: 1. What is the effect of AVR therapy on pain levels score compared with routine care during chemotherapy session among cancer patients? 2. What is the effect of AVR therapy on the stress levels compared with routine care during chemotherapy session among cancer patients? 3. What is the effect of AVR therapy on the anxiety compared with routine care during chemotherapy session among cancer patients? 4. What is the effect of AVR therapy on the general SE compared with routine care during chemotherapy session among cancer patients? The participants divided into two groups, the intervention group, which receives AVR, and the control group, which receives standard treatment. The study used a pretest and posttest design to assess the effect of AVR on the study variables (pain, stress, anxiety and self-efficacy).
Study details
- Official title
- The Effect of Using Augmented Virtual Reality on Pain, Stress, Anxiety, and Self-Efficacy Among Adult Cancer Patients Undergoing Chemotherapy in the West Bank
- Conditions
- Cancer and Chemotherapy Related Anemia
- Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)
- Interventions
- Behavioral: AVR Group (Chemotherapy + AVR)
- Sponsor
- Arab American University (Palestine)
- Start date
- 2023-06-01
- Primary completion
- 2023-09-30
- Sex
- All
- Age range
- from 18 Years to 60 Years
- Results posted
- No results posted in this snapshot
- Countries
- Palestinian Territories
- Total sites listed
- 3
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Adult patients aged 18-60 years undergoing chemotherapy for breast or colon cancer. 2. Stage I or II cancer, as defined by the study protocol. 3. Manageable levels of pain, anxiety, and stress, appropriate for participation in the intervention. \- Exclusion Criteria: 1. Age over 60 years. 2. Cancer types other than breast or colon cancer. 3. Severe pain, anxiety, or stress that could interfere with participation or require intensive care beyond the study scope.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07152938